Substance / Medication

Hematite

Overview

Active Ingredient
ferric oxide
RxNorm CUI
1310572

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Comparison of hematite-facilitated anaerobic digestion of acetate and beef extract.
Zhu Dan, Wang Jin, Chen Tian-Hu et al. · Environ Technol · 2015
PMID: 25746085Observational
Controls on Fe(II)-activated trace element release from goethite and hematite.
Frierdich Andrew J, Catalano Jeffrey G · Environ Sci Technol · 2012
PMID: 22185654Observational
Comparison of micro- and nanoscale Fe⁺³-containing (Hematite) particles for their toxicological properties in human lung cells in vitro.
Bhattacharya Kunal, Hoffmann Eik, Schins Roel F P et al. · Toxicol Sci · 2012
PMID: 22262566Observational
Comparison of hematite/Fe(II) systems with cement/Fe(II) systems in reductively dechlorinating trichloroethylene.
Kim Hong-Seok, Kang Wan-Hyup, Kim Meejeong et al. · Chemosphere · 2008
PMID: 18597815Observational
A model-based evaluation of sorptive reactivities of hydrous ferric oxide and hematite for U(VI).
Jang Je-Hun, Dempsey Brian A, Burgos William D · Environ Sci Technol · 2007
PMID: 17626429Observational
Combined remote LIBS and Raman spectroscopy at 8.6m of sulfur-containing minerals, and minerals coated with hematite or covered with basaltic dust.
Sharma S K, Misra A K, Lucey P G et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2007
PMID: 17723318Observational
Arsenic sorption onto natural hematite, magnetite, and goethite.
Giménez Javier, Martínez María, de Pablo Joan et al. · J Hazard Mater · 2007
PMID: 16978766Observational
Fe(II) sorption on hematite: new insights based on spectroscopic measurements.
Larese-Casanova Philip, Scherer Michelle M · Environ Sci Technol · 2007
PMID: 17310709Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Hematite (substance)
SNOMED CT
43564000
UMLS CUI
C0060240
RxNorm CUI
1310572

Clinical Data

This intervention maps to 8 entities in the Healos knowledge graph.

1
Conditions
3
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Hematite — Conditions, Biomarkers & Specialists | Healos | Ltrl